National Account Director

Intellia•Cambridge, MA

4d•$225,000 - $275,000•Remote

About The Position

Why Join Intellia? Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases. Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done. We want all of our people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do together. The National Account Director – Public Payer will play a critical leadership role in shaping and executing our U.S. market access strategy with state Medicaid programs, Medicaid Managed Care Organizations (MCOs), federal payers, and select regional government-affiliated health plans in preparation for our first gene editing therapy launch. This is a high-impact, field-based position responsible for building relationships with key government payer stakeholders, communicating product value, and securing favorable coverage and reimbursement pathways within the unique regulatory and budgetary framework of public payer systems. This is a highly strategic, hands-on role that is ideal for an experienced national account professional who thrives in fast-paced, build-from-scratch environments and understands the complexity of launching innovative, high-value therapies in Medicaid and government-funded healthcare programs.

Requirements

Proven track record of managing Medicaid and/or government payer accounts, including pre-launch and launch readiness for specialty, rare disease, or high-cost transformative therapies (e.g., cell & gene therapy experience preferred).
Deep understanding of Medicaid structures (FFS vs. managed care), state-specific policy environments, Medicaid Drug Rebate Program, supplemental rebates, and Best Price dynamics.
Experience with medical benefit products (preferred in CGT).
Experience with innovative reimbursement models applicable to Medicaid, including potential contracting, performance guarantees, and risk-sharing agreements.
Strong grasp of government payer decision-making processes, state P&T committee operations, PDL management, utilization management, prior authorization criteria, and specialty pharmacy/distribution complexities within Medicaid.
Demonstrated ability to thrive in early-stage or launch environments, operating with agility, strategic foresight, and adaptability within government and regulatory frameworks.
Excellent communicator who can convey complex scientific, economic, and health equity data to diverse audiences, including state officials, policy makers, and MCO leaders.
Strong project management, cross-functional leadership, and stakeholder engagement skills.
Excellent negotiation skills and analytical capabilities, with experience modeling financial and clinical impact for state budgets.
Comfortable operating in ambiguity with a strong bias for action, accountability, and mission-driven problem solving.
Commitment to health equity and understanding of the unique needs and barriers faced by Medicaid populations.
Bachelor's degree required; MBA or other graduate degree preferred.
7+ years of pharmaceutical or biotech market access experience, Medicaid/Payer account management, or managed markets strategy.
Travel: Up to 50%, including partner meetings, conferences, and internal cross-functional workshops.

Responsibilities

Lead strategic engagement with: State Medicaid programs (FFS and managed care), Medicaid MCOs (e.g., Centene, Molina, UnitedHealthcare Community & State, Elevance Medicaid plans Federal/government payers (e.g., VA, DoD/TRICARE, IHS) to cover VISNs and MTFs; and interact with the DOD P&T and VA PBM as needed.
Build and manage relationships with key decision-makers across: Medicaid: Medicaid agencies, state pharmacy directors, P&T committees, and Medicaid MCO medical/pharmacy leadership. Federal: VA PBM, DOD P&T, BAP, MTFs and VISNs
Navigate the unique regulatory, legislative, and budgetary constraints of Medicaid programs, including understanding Drug Rebate Program requirements, Best Price implications, and state budgetary cycles.
Analyze state-specific Medicaid policies, utilization management criteria, and preferred drug lists (PDLs) to anticipate coverage barriers and inform access strategies.
Develop and execute early account engagement plans in anticipation of launch, educating Medicaid stakeholders on gene editing science, disease burden, patient population overlap with Medicaid beneficiaries, and anticipated value proposition—with sensitivity to health equity and access considerations.
Partner with internal teams (Market Access Strategy, Contracts and Pricing, HEOR, Medical Affairs, Clinical, Regulatory, Patient Services) to develop and tailored payer-facing materials, including early scientific exchange, evidence dossiers, state-specific budget impact models, PIE presentations, and health equity analyses.
Drive Medicaid payer insight generation to inform state-level advocacy efforts in pre-launch and launch phases.
Collaborate with internal teams to monitor state legislation, Medicaid policy developments, and advocacy opportunities that impact access to gene editing and high-cost cell & gene therapies.
Work closely with internal launch and hub teams to support pull-through planning, specialty pharmacy/distribution strategy specific to Medicaid (e.g., 340B considerations), and affordability/access solutions tailored to Medicaid populations.
If required, identify, shape, and lead negotiation of value-based, outcomes-based, or performance-based supplemental rebate agreements aligned with company objectives, product profile, and Medicaid/MCO priorities.
Monitor and influence Medicaid policy development, coverage determinations, and utilization management protocols relevant to gene editing and transformative therapies, including participation in and coordination of cross-functional team members in P&T and DUR meetings for strategic states Monitor Federal policy and formula placement in the VA and DOD; including submission of DOD RFP formulary bid
Serve as the internal voice of Medicaid and government payers, providing strategic guidance to leadership on coverage risks, opportunities, health equity implications, and market dynamics unique to public payer systems.
Ensure all engagements and materials are fully compliant with legal, regulatory, compliance, and corporate standards, including OIG guidance, Anti-Kickback Statute, Medicaid Drug Rebate Program rules, and transparency requirements.
Serve as a key commercial liaison across internal stakeholders, including Market Access Leadership, Medical Affairs, Patient Services/Hub, Marketing, Legal, Finance, and Regulatory, to ensure alignment on strategic initiatives and execution plans that support Medicaid and government account objectives.
Partner closely with Commercial Field Access, Trade, Channel, Medical, HEOR and Hub Operations teams to co-develop and deliver integrated account strategies that enhance access, affordability, and distribution of gene therapy products across Medicaid FFS, Medicaid MCOs, specialty pharmacies, 340B entities, and other relevant channels.
Partner and strategize with internal National Account Directors as required for related Commercial accounts across Managed Medicaid and Medicare Advantage
Lead cross-functional account planning sessions to synthesize Medicaid-specific market insights, anticipate payer and patient needs, and develop tailored engagement models that drive optimal therapeutic adoption and long-term value creation within public programs.
Collaborate with HEOR, Health Economics, and Policy teams to translate complex scientific and economic value propositions into compelling narratives for diverse Medicaid stakeholders.
Facilitate seamless internal coordination and communication to ensure the delivery of compliant, consistent messaging and solutions that reflect both the scientific innovation and the public health mission alignment of the organization.
Drive organizational readiness and pull-through efforts across functional teams pre- and post-launch to ensure market access success in the highly regulated, budget-sensitive, and politically complex Medicaid and government payer landscape.